Gossamer Bio Newsroom

12 Health Care Stocks Moving In Thursday's Pre-Market Session

BenzingaDec 13 05:05

After Plunging -15.92% in 4 Weeks, Here's Why the Trend Might Reverse for Gossamer Bio (GOSS)

Zacks Nov 14 21:40

Gossamer Bio (GOSS) Gets a Buy From Oppenheimer

TipRanksNov 12 20:46 · Ratings

HC Wainwright & Co. Reiterates Buy on Gossamer Bio, Maintains $10 Price Target

BenzingaNov 11 23:10 · Ratings

Gossamer Bio Analyst Ratings

BenzingaNov 11 23:08 · Ratings

Promising Progress and Expansion Potential of Gossamer Bio's Seralutinib Drive Buy Rating

TipRanksNov 11 19:17 · Ratings

Gossamer Bio, Inc. (NASDAQ:GOSS) Just Reported And Analysts Have Been Lifting Their Price Targets

Yahoo FinanceNov 10 20:03

Gossamer Bio Reports Revenue Growth Amid Strategic Collaborations

TipRanksNov 9 12:24

Gossamer Bio: Q3 Earnings Snapshot

Yahoo FinanceNov 8 05:59

Earnings Flash (GOSS) GOSSAMER BIO Reports Q3 Revenue $9.5M

MT NewswiresNov 8 05:15

Gossamer Bio | 10-Q: Q3 2024 Earnings Report

SECNov 8 05:04 · Announcements

Gossamer Bio | 8-K: Gossamer Bio Announces Third Quarter 2024 Financial Results and Provides Business Update

SECNov 8 05:04

Gossamer Bio 3Q Loss/Shr 14c >GOSS

Dow JonesNov 8 05:03

Express News | Gossamer Bio Announces Third Quarter 2024 Financial Results and Provides Business Update

BreakingsNov 8 05:03

Express News | Gossamer Bio Q3 Operating Expenses USD 43.399 Million

BreakingsNov 8 05:03

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

BusinesswireOct 8 05:01

Express News | Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

BreakingsOct 8 05:01

Several Insiders Invested In Gossamer Bio Flagging Positive News

Yahoo FinanceOct 3 20:10

12 Health Care Stocks Moving In Wednesday's After-Market Session

BenzingaOct 3 04:31

Bullish Outlook on Gossamer Bio's Seralutinib Efficacy and Market Potential

TipRanksSep 17 21:35